Categories: News

poLight ASA receives purchase order for TWedge® wobulator technical samples from a top tier consumer OEM customer

TØNSBERG, Norway, Nov. 21, 2024 /PRNewswire/ — poLight ASA (OSE: PLT) today announced that the company has received a purchase order worth approximately NOK 500,000 to supply its TWedge® wobulator technical samples to a top tier consumer OEM customer for an AR/MR application.

“Our customer interactions related to TWedge® wobulator technology provide key insights as we define this potential new product,” said Dr. Øyvind Isaksen, CEO of poLight ASA. “TWedge® wobulator is based on the same tunable optics technology platform as our TLens® product used in numerous auto focus imaging systems. While there will be many steps between technical sample evaluation, productization, and potential mass production supply into customer devices, this milestone is an important step for our TWedge® wobulator technology and we are encouraged by the continued interests from many of our customers. In addition, this customer is also evaluating our TLens® product to differentiate their imaging device. We have no doubt that both TLens® and TWedge® wobulator technology can solve many AR/MR design challenges.”

The delivery of the TWedge® technical samples is expected to be completed in Q1 2025.

CONTACT:

For further information, please contact:

Dr Øyvind Isaksen, CEO, poLight ASA: +47 90 87 63 98
 

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/polight/r/polight-asa-receives-purchase-order-for-twedge–wobulator-technical-samples-from-a-top-tier-consumer,c4070063

View original content:https://www.prnewswire.com/news-releases/polight-asa-receives-purchase-order-for-twedge-wobulator-technical-samples-from-a-top-tier-consumer-oem-customer-302313285.html

SOURCE poLight

Staff

Recent Posts

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

8 hours ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

11 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

11 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

11 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

11 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

11 hours ago